IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1701 
Small font sizeDefault font sizeIncrease font size
Navigate Here
    Next article
    Previous article
    Table of Contents

Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed563    
    Printed34    
    Emailed0    
    PDF Downloaded94    
    Comments [Add]    

Recommend this journal

 

 EDITORIAL
Year : 2018  |  Volume : 50  |  Issue : 5  |  Page : 225-226

Developing and sustaining India's capacity for preclinical drug discovery


1 School of Biomedical Sciences (Faculty of Biological Sciences), University of Leeds, Leeds, UK
2 Director of Sat Kaival College of Pharmacy (SKCOP), General Secretary, Indian Pharmacological Society (IPS), Sarsa, Gujarat, India
3 Drug Toxicology Division, National Institute of Nutrition, Hyderabad, India
4 Department of Pharmacology, PGIMER, Chandigarh, India

Correspondence Address:
Dr. David I Lewis
School of Biomedical Sciences (Faculty of Biological Sciences), University of Leeds, Leeds
UK
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijp.IJP_641_18

Rights and Permissions








[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow